Toastmasters International Announces Matt Abrahams as its 2025 Golden Gavel Recipient
"
Matt is an accomplished writer whose articles have appeared in the GSB, Fast Company, Toastmasters Magazine, Inc.com, and Quartz. He has also published several research articles on strategic planning, persuasion, and interpersonal communication. Prior to teaching, Matt held senior leadership positions at several software companies, where he created and ran global learning and development organizations.
"Being named the recipient of the 2025 Golden Gavel Award is an incredible honor," says Abrahams. "I'm excited to share my passion for communication and the journey we can all take to become more effective planned and spontaneous communicators."
Abrahams will accept the award and address attendees during a presentation on Friday, Aug. 22, at the
To learn more about the 2025 International Convention,
About Toastmasters International
Toastmasters International is a nonprofit educational organization that builds confidence and teaches public speaking skills through a worldwide network of clubs that meet online and in person. In a supportive community or corporate environment, members prepare and deliver speeches, respond to impromptu questions, and give and receive constructive feedback. It is through this regular practice that members are empowered to meet personal and professional communication goals. Founded in 1924, the organization is headquartered in Englewood,
View original content to download multimedia:https://www.prnewswire.com/news-releases/toastmasters-international-announces-matt-abrahams-as-its-2025-golden-gavel-recipient-302381543.html
SOURCE Toastmasters International
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Innovative Environmental Testing Franchise Opportunity Launches with The Mobile Lab™
- Former South Carolina Governor, David Beasley, Launches Breaking Bread Together as a National Movement to Bridge America's Divides
- Psilera Appoints Neuroscience Veteran Allyson Gage, PhD, as Vice President, Clinical Development to Lead Upcoming Phase 1 Clinical Trial
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
Twitter, IPOSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share